Developer of electroceuticals designed to address prevalent neurological pain diseases. The company's product offers an innovative FDA-authorized, non-invasive, smartphone-operated, prescribed wearable, use-and-dispose, and provides temporary or long-term pain relief, enabling patients to treat acute migraines affordably.
Developer of a virtual neurology clinic platform intended to provide improved access to care for patients suffering from neurological disorders. The company's platform helps people to track their symptoms, seamlessly share them with a licensed doctor and get personalized care from the comfort of their home, enabling users to easily get improved treatments for migraine and chronic headaches.
Developer of non-invasive neurostimulation products designed to treat global health epidemics. The company's medical device technology offers transdermal activation of the homeostatic nuclei of the brainstem and hypothalamus to allow for alterations in autonomic function, circadian regulation, and neuro-metabolic influence, enabling healthcare providers to provide drug-free options and improve patients' health outcomes.
Developer of non-surgical intervention device designed to treat chronic rhinitis safely. The company specializes in minimally invasive hand-held radio-frequency devices that are introduced through the nostrils into the nasal cavity under direct endoscopic visualization where it deploys a microelectrode array that delivers targeted energy to interrupt the autonomic function within the mucosal structures of nasal cavities which will reverse the inflammatory cascade, enabling surgeons to treat patients in an office setting, removing the complications and costs associated with most surgical procedures.